These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38106464)

  • 1. Stability Studies of Kynurenine Pathway Metabolites in Blood Components Define Optimal Blood Processing Conditions.
    Heng B; Pires AS; Chow S; Krishnamurthy S; Bonnell B; Bustamante S; Guillemin GJ
    Int J Tryptophan Res; 2023; 16():11786469231213521. PubMed ID: 38106464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
    Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
    Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
    J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum kynurenine pathway metabolic profile is associated with overweight and obesity in multiple sclerosis.
    Kupjetz M; Patt N; Joisten N; Ueland PM; McCann A; Gonzenbach R; Bansi J; Zimmer P
    Mult Scler Relat Disord; 2023 Apr; 72():104592. PubMed ID: 36881945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study.
    Parker DC; Kraus WE; Whitson HE; Kraus VB; Smith PJ; Cohen HJ; Pieper CF; Faldowski RA; Hall KS; Huebner JL; Ilkayeva OR; Bain JR; Newby LK; Huffman KM
    J Alzheimers Dis; 2023; 91(3):1141-1150. PubMed ID: 36565121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Tryptophan Supplementation and Exercise on the Fate of Kynurenine Metabolites in Mice and Humans.
    Valente-Silva P; Cervenka I; Ferreira DMS; Correia JC; Edman S; Horwath O; Heng B; Chow S; Jacobs KR; Guillemin GJ; Blomstrand E; Ruas JL
    Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis.
    Lovelace MD; Varney B; Sundaram G; Franco NF; Ng ML; Pai S; Lim CK; Guillemin GJ; Brew BJ
    Front Immunol; 2016; 7():246. PubMed ID: 27540379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease.
    Rodrigues FB; Byrne LM; Lowe AJ; Tortelli R; Heins M; Flik G; Johnson EB; De Vita E; Scahill RI; Giorgini F; Wild EJ
    J Neurochem; 2021 Jul; 158(2):539-553. PubMed ID: 33797782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease.
    Pires AS; Gupta S; Barton SA; Vander Wall R; Tan V; Heng B; Phillips JK; Guillemin GJ
    Int J Tryptophan Res; 2022; 15():11786469221126063. PubMed ID: 36329761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes.
    Fiedorowicz M; Choragiewicz T; Thaler S; Schuettauf F; Nowakowska D; Wojtunik K; Reibaldi M; Avitabile T; Kocki T; Turski WA; Kaminska A; Grieb P; Zrenner E; Rejdak R; Toro MD
    Front Physiol; 2019; 10():1254. PubMed ID: 31632294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of d-amino acid oxidase in the production of kynurenine pathway metabolites from d-tryptophan in mice.
    Notarangelo FM; Wang XD; Horning KJ; Schwarcz R
    J Neurochem; 2016 Feb; 136(4):804-814. PubMed ID: 26661897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
    Haroon E; Welle JR; Woolwine BJ; Goldsmith DR; Baer W; Patel T; Felger JC; Miller AH
    Neuropsychopharmacology; 2020 May; 45(6):998-1007. PubMed ID: 31940661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Involvement of Kynurenine Pathway in Neurodegenerative Diseases.
    Martins LB; Silveira ALM; Teixeira AL
    Curr Neuropharmacol; 2023; 21(2):260-272. PubMed ID: 36154606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary electrochromatography-mass spectrometry of kynurenine pathway metabolites.
    Chawdhury ASMMR; Shamsi SA; Miller A; Liu A
    J Chromatogr A; 2021 Aug; 1651():462294. PubMed ID: 34098249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
    Front Immunol; 2022; 13():997240. PubMed ID: 36263032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Kynurenine Pathway in the (Patho) physiology of Maternal Pregnancy and Fetal Outcomes: A Systematic Review.
    van Zundert SK; Broekhuizen M; Smit AJ; van Rossem L; Mirzaian M; Willemsen SP; Danser AJ; De Rijke YB; Reiss IK; Merkus D; Steegers-Theunissen RP
    Int J Tryptophan Res; 2022; 15():11786469221135545. PubMed ID: 36467775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.
    Ciapała K; Mika J; Rojewska E
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
    Song P; Ramprasath T; Wang H; Zou MH
    Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.